These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31979216)

  • 21. Overexpression of Polo-like kinase1 (PLK1) in chondrosarcoma and its implications for cancer progression.
    Li K; Ma H; Zheng X; Hu Y; Wang Y; Zhang K; Chen J; Qi Y; Jiang J; Pang L; Tao L; Gu W; Li F; Zou H
    Int J Clin Exp Pathol; 2018; 11(3):1707-1711. PubMed ID: 31938273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.
    Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q
    Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers.
    Takahashi T; Sano B; Nagata T; Kato H; Sugiyama Y; Kunieda K; Kimura M; Okano Y; Saji S
    Cancer Sci; 2003 Feb; 94(2):148-52. PubMed ID: 12708489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the discovery of polo-like kinase inhibitors.
    McInnes C; Mezna M; Fischer PM
    Curr Top Med Chem; 2005; 5(2):181-97. PubMed ID: 15853646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer.
    Takeshita T; Asaoka M; Katsuta E; Photiadis SJ; Narayanan S; Yan L; Takabe K
    Am J Transl Res; 2019; 11(10):6507-6521. PubMed ID: 31737202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
    Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
    Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
    Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
    Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the
    Van den Bossche J; Deben C; Op de Beeck K; Deschoolmeester V; Hermans C; De Pauw I; Jacobs J; Van Schil P; Vermorken JB; Pauwels P; Peeters M; Lardon F; Wouters A
    J Cancer; 2017; 8(8):1441-1452. PubMed ID: 28638459
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS.
    Jayashree B; Srimany A; Jayaraman S; Bhutra A; Janakiraman N; Chitipothu S; Krishnakumar S; Baddireddi LS; Elchuri S; Pradeep T
    Anal Bioanal Chem; 2016 Aug; 408(20):5623-32. PubMed ID: 27277815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting PLK1 expression.
    Huang WJ; Wang Y; Liu S; Yang J; Guo SX; Wang L; Wang H; Fan YF
    Cancer Lett; 2018 May; 422():70-80. PubMed ID: 29454093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
    Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
    Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway.
    Zhao L; Li C; Liu F; Zhao Y; Liu J; Hua Y; Liu J; Huang J; Ge C
    Onco Targets Ther; 2017; 10():2115-2126. PubMed ID: 28442920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
    Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
    Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
    Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
    Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of activated PPARgamma on the expression of PTEN gene in pancreatic cancer cells].
    Bai MH; Ma HB; Wang XJ; Liu XX; Xue XH; Xue FJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):717-20. PubMed ID: 18616919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal expression of PTEN and PIK3CA in pemetrexed-resistant human pancreatic cancer cell line Patu8988.
    Shi X; Gu HT; Lin SB; Zhang Y; Yang J; Qian CJ
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between down-regulation of HIC1 and PTEN genes and dysfunction of pancreatic islet cells in diabetic rats.
    Liu HL; Yang HY; Liu LX; Chen Y; Kuang HY; Zhang HJ; Yin HQ
    Acta Histochem; 2011 May; 113(3):340-8. PubMed ID: 20129651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.